Lab-quality results delivered with speed and efficiency where you need them

The Stratus® CS 200 Acute Care™ Analyzer* delivers lab-quality Troponin I results for chest-pain patients with speed and efficiency at the point of care. It delivers the first result in as fast as 14 minutes to support rapid, informed decision making that may lead to better patient care. Clinicians may individually select and test multiple assays from a single sample, on a single run, and on a single instrument. Simple operation and advanced connectivity help to promote consistent results and efficient workflow.

Features & Benefits

Lab-quality ResultsThe analyzer delivers lab-quality results at the point of care and with the speed needed for cardiac patients. It offers a comprehensive cardiac menu, including guideline acceptable sensitive troponin I and D-dimer assays, and automatically spins whole blood into plasma for testing, thereby reducing the risk of biohazard exposure. The Stratus CS 200 system ensures results will be comparable to lab tests run on plasma samples.

Simple Steps for Fast and Consistent Results

With the first result available in as fast as 14 minutes and subsequent results within 4 minutes, the Stratus CS 200 system allows for faster diagnosis of patients.

The acute cardiac care system accepts whole blood samples in a collection tube; no sample preparation is required.

Simply input sample and walk away—minimal operator involvement.

A user-friendly touchscreen interface allows for easier navigation through the instrument’s screens.

The bar-code reader eliminates the need for manual entry and reduces potential for error.

Efficient Workflow

Bidirectional connectivity feature with third-party data managers allows for the safe and secure transmission of results.

Remote monitoring saves time by eliminating the need to walk to the analyzer to check when calibration is due.

Ample memory allows storage of up to 50 patient results and up to 500 operator IDs.

Assays

Multiple cardiac assays are available to meet your point-of-care testing demands. Test cartridges are individually packaged, providing flexibility to select appropriate tests based on patient need. As many as four assays can be run simultaneously per patient sample on the Stratus CS 200 system*

Guideline Acceptable Sensitive Troponin I AssayThe cTnl assay meets the ESC/ACC Joint Committee recommendations of ≤10% CV at the 99th percentile of a normal population. The assay is used for the measurement of cardiac troponin I to aid in the diagnosis of AMI and in the risk stratification of patients with acute coronary syndromes (ACS).

D-dimer Assay (with Pulmonary Embolism Exclusion†D-dimer is a quantitative measurement of cross-linked fibrin degradation products (D-dimer) in human citrated or heparinized plasma. The D-dimer assay is intended for use in conjunction with a non-high clinical pretest probability (PTP) assessment model to exclude pulmonary embolism (PE) disease and as an aid in the diagnosis of venous thromboembolism (VTE) [deep vein thrombosis (DVT) or PE].

CKMB Mass AssayCKMB is for the measurement of the MB isoenzyme of creatine kinase in heparinized whole blood/plasma. CKMB measurements can be used as an aid in diagnosing acute myocardial infarction.

Myoglobin AssayMyoglobin measures myoglobin in heparinized whole blood /plasma. Myoglobin measurements can be used as an aid in diagnosing myocardial infarction.

NT-proBNP AssayNT-proBNP is a quantitative measurement of N-terminal pro-brain natriuretic peptide (NT-proBNP) in heparinized plasma. Measurements of NT-proBNP are used as an aid in the diagnosis of individuals suspected of having congestive heart failure (CHF). The test is further indicated for the risk stratification of patients with acute coronary syndrome and heart failure, resulting from left-ventricular dysfunction.CardioPhase® hsCRP AssayMeasurement of CRP is useful for the detection and evaluation of infection, tissue injury, inflammatory disorders, and associated diseases. High-sensitivity CRP (hsCRP) measurements may be used as an independent risk marker for the identification of individuals at risk for future cardiovascular disease. Measurements of hsCRP, when used in conjunction with traditional clinical laboratory evaluation of acute coronary syndromes, may be useful as an independent marker of prognosis for recurrent events, in patients with stable coronary disease or acute coronary syndromes.

Quantitative βhCG AssayRunning STAT βhCG ensures that clinicians know of any potential pregnancies in their cardiac patients, and can recommend the most appropriate diagnostic assessments for those patients.

Technical Specifications

Stratus® CS 200 Acute Care™ Analyzer* and Assay Specifications

Troponin I Assay

CKMB Assay

NT-proBNP Assay

D-dimer Assay

hsCRP Assay

Myoglobin Assay

βhCG Assay

Assay Range

0.03–50 μg/L (30–50,000 ng/L)

0.3–150 μg/L (ng/mL)

15–20,000 pg/mL

6–5000 μg/L (ng/mL) FEU

0.1–50 mg/L

1–900 μg/L (ng/mL)

0.5–1250 IU/L (mIU/mL)

Analytical Sensitivity

<0.03 μg/L (<30 ng/L)

0.3 μg/L

15.0 pg/mL

6.0 μg/L FEU

≤0.1 mg/L

1.0 μg/L

<0.5 IU/L

Assay Characteristics

10% at 0.06 μg/L (10% at 60 ng/L)

4.0% at 3.7 μg/L

4.4% at 96.6 pg/mL

4.1% at 412 μg/L

6.8% at 1.16 mg/L

3.4% at 56 μg/L; 4.6% at 142 μg/L‡

2.5% at 27.1 IU/L§

Calibration Stability

60 days

60 days

30 days

60 days

60 days

60 days

90 days

Please refer to the assay package inserts for more detailed information.